EltzschigHKEckleT. Ischemia and reperfusion—from mechanism to translation. Nat Med. 2011;17:1391-1401.
2.
GoASMozaffarianDRogerVL; American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation2014;129:399-410.
3.
MurryCEJenningsRBReimerKA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
4.
KlonerRABolliRMarbanEReinlibLBraunwaldE. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation. 1998;97:1848-1867.
5.
FrankABonneyMBonneySWeitzelLKoeppenMEckleT. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth. 2012;16:123-132.
6.
BonneySHughesKEckleT. Anesthetic cardioprotection: the role of adenosine [published online February 4, 2014]. Curr Pharm Des. doi:10.2174/138161-2820666140204102524.
7.
RedelALangeMJazbutyteV. Activation of mitochondrial large-conductance calcium-activated K+ channels via protein kinase A mediates desflurane-induced preconditioning. Anesth Analg. 2008;106:384-391.
8.
StumpnerJTischer-ZeitzTFrankA. The role of cyclooxygenase-1 and -2 in sevoflurane-induced postconditioning against myocardial infarction [published online February 25, 2014]. Semin Cardiothorac Vasc Anesth. doi:10.1177/1089253214523683.
9.
SolomonSDMcMurrayJJPfefferMA; Adenoma Prevention with Celecoxib Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352:1071-1080.
